phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jallouk, AP; Myerson, JW; Palekar, RU; Pan, H; Wickline, SA | 1 |
| Klegerman, ME; McPherson, DD; Zou, Y | 1 |
2 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Atherosclerosis
| Article | Year |
|---|---|
Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antithrombins; Apolipoproteins E; Atherosclerosis; Blood Coagulation; Capillary Permeability; Carotid Artery Injuries; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Humans; Inflammation Mediators; Magnetic Resonance Spectroscopy; Male; Mice, Knockout; Nanoparticles; Plaque, Atherosclerotic; Signal Transduction; Thrombin; Thrombosis; Time Factors | 2016 |
Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antibodies; Antibody Affinity; Atherosclerosis; Contrast Media; Drug Delivery Systems; Enzyme Activation; Fibrin; Fibrinolytic Agents; Humans; Liposomes; Serine Proteinase Inhibitors; Tissue Plasminogen Activator; Ultrasonography | 2008 |